Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer. | Front Immunol | 2022 | 36211375 | PubTator, text mining | PubMed |
| Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods. | Front Immunol | 2022 | 36203586 | PubTator, text mining | PubMed |
| Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer. | Front Immunol | 2022 | 36203562 | PubTator, text mining | PubMed |
| Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their "virtual" secretome. | Front Cell Dev Biol | 2022 | 36200044 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cells. | Cell Metab | 2022 | 36198295 | PubTator, text mining | PubMed |
| Role of 5-methylcytosine in determining the prognosis, tumor microenvironment, and applicability of precision medicine in patients with hepatocellular carcinoma. | Front Genet | 2022 | 36186468 | PubTator, text mining | PubMed |
| Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells. | Microb Pathog | 2022 | 36174833 | PubTator, text mining | PubMed |
| The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. | Clin Proteomics | 2022 | 36171541 | PubTator, text mining | PubMed |
| CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance. | Int J Inflam | 2022 | 36164329 | PubTator, text mining | PubMed |
| Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers. | Clin Cancer Res | 2022 | 36161312 | PubTator, text mining | PubMed |
| Immune status for monitoring and treatment of bladder cancer. | Front Immunol | 2022 | 36159866 | PubTator, text mining | PubMed |
| Human Plasma Proteome During Normal Pregnancy. | J Proteome Res | 2022 | 36154181 | PubTator, text mining | PubMed |
| Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. | Clin Epigenetics | 2022 | 36153611 | PubTator, text mining | PubMed |
| A Parametric Study on a Paper-Based Bi-Material Cantilever Valve. | Micromachines (Basel) | 2022 | 36144125 | PubTator, text mining | PubMed |
| Current Status of 68Ga-Pentixafor in Solid Tumours. | Diagnostics (Basel) | 2022 | 36140541 | PubTator, text mining | PubMed |
| A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease. | Cells | 2022 | 36139421 | PubTator, text mining | PubMed |
| Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation. | PLoS Pathog | 2022 | 36121891 | PubTator, text mining | PubMed |
| An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors. | Front Oncol | 2022 | 36119525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=35